Myelofibrosis: Diagnosis and Risk Stratification

preview_player
Показать описание
Expert panelists Harry P. Erba, MD, PhD; Jamile M. Shammo, MD, FASCP, FACP; Ruben A. Mesa, MD, FACP; Srdan Verstovsek, MD, PhD; and Rami Komrokji, MD, review the appropriate methods of diagnosing and stratifying patients with myelofibrosis and debate the clinical value of prognostic scoring.
Рекомендации по теме